On February 25, 2025 Alector, Inc. (Nasdaq: ALEC), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, reported that management will participate in the following upcoming investor conferences (Press release, Alector, FEB 25, 2025, View Source [SID1234650514]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen 45th Annual Health Care Conference (Boston, Massachusetts)
Tuesday, March 4, 2025, at 9:10 a.m. ET, corporate presentation
Leerink Partners Global Biopharma Conference (Miami, Florida)
Tuesday, March 11, 2025, at 8:40 a.m. ET, corporate presentation
Stifel 2025 Virtual CNS Forum
Tuesday, March 18, 2025, at 2:00 p.m. ET, corporate presentation

A webcast of each conference presentation will be available on the "Events & Presentations" page within the Investors section of the Alector website at View Source Replays of the webcasts will be available on the Alector website for 90 days following the presentation dates.